Inactive matrix gla-protein is associated with arterial stiffness in an adult population-based study

Hypertension

Volumn 66, Issue 1, 2015, Pages 85-92

  Pivin, Edward ^a   Ponte, Belen ^c   Pruijm, Menno ^b   Ackermann, Daniel ^d   Guessous, Idris ^a,c   Ehret, Georg ^e,f   Liu, Yan Ping ^g   Drummen, Nadja E A ^h   Knapen, Marjo H J ^h   Pechere Bertschi, Antoinette ^c   Paccaud, Fred ^a   Mohaupt, Markus ^d   Vermeer, Cees ^h   Staessen, Jan A ^g   Vogt, Bruno ^d   Martin, Pierre Yves ^c   Burnier, Michel ^b   Bochud, Murielle ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Canton Hospital of the University of Geneva   (Switzerland)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

calcium binding protein; matrix Gla protein; pulse wave velocity; vascular stiffness; Vitamin K

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MATRIX GLA PROTEIN; OSTEOCALCIN; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; GLUCOSE BLOOD LEVEL; LIPID; SCLEROPROTEIN;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PULSE WAVE; SMOKING; SWITZERLAND; SYSTOLIC BLOOD PRESSURE; TONOMETRY; AGE; AGED; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; CLINICAL TRIAL; COMORBIDITY; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; KIDNEY; MULTICENTER STUDY; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; BODY MASS INDEX; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HEMODYNAMICS; HUMANS; KIDNEY; LIPIDS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PULSE WAVE ANALYSIS; SAMPLING STUDIES; SMOKING; SWITZERLAND; VASCULAR STIFFNESS;

EID: 84940024636     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05177     Document Type: Article

References (47)

1. O'Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE., Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens 2002 15 426 444
2. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J., Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006 113 664 670. doi: 10.1161/CIRCULATIONAHA.105.579342
3. Wang KL, Cheng HM, Sung SH, Chuang SY, Li CH, Spurgeon HA, Ting CT, Najjar SS, Lakatta EG, Yin FC, Chou P, Chen CH., Wave reflection and arterial stiffness in the prediction of 15-year all-cause and cardiovascular mortalities: a community-based study. Hypertension 2010 55 799 805. doi: 10.1161/HYPERTENSIONAHA.109.139964
4. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ., Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010 121 505 511. doi: 10.1161/CIRCULATIONAHA.109.886655
5. Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg PL., The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Expr 1998 8 357 375
6. Price PA, Urist MR, Otawara Y., Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 1983 117 765 771
7. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G., Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997 386 78 81. doi: 10.1038/386078a0
8. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL., High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994 93 2393 2402. doi: 10.1172/JCI117246
9. Shanahan CM, Weissberg PL, Metcalfe JC., Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res 1993 73 193 204
10. Price PA, Faus SA, Williamson MK., Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998 18 1400 1407
11. Price PA, Rice JS, Williamson MK., Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human. Protein Sci 1994 3 822 830. doi: 10.1002/pro.5560030511
12. Wallin R, Cain D, Sane DC., Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells-A cell system which resembles the system in bone cells. Thromb Haemost 1999 82 1764 1767
13. Goiko M, Dierolf J, Gleberzon JS, Liao Y, Grohe B, Goldberg HA, de Bruyn JR, Hunter GK., Peptides of Matrix Gla protein inhibit nucleation and growth of hydroxyapatite and calcium oxalate monohydrate crystals. PLoS One 2013 8 e80344. doi: 10.1371/journal.pone.0080344
14. Boström K., Insights into the mechanism of vascular calcification. Am J Cardiol 2001 88 2A 20E 22E
15. Liabeuf S, Bourron O, Olivier B, Vemeer C, Theuwissen E, Magdeleyns E, Aubert CE, Brazier M, Mentaverri R, Hartemann A, Massy ZA., Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein. Cardiovasc Diabetol 2014 13 85. doi: 10.1186/1475-2840-13-85
16. Dalmeijer GW, van der Schouw YT, Vermeer C, Magdeleyns EJ, Schurgers LJ, Beulens JW., Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women. J Nutr Biochem 2013 24 624 628. doi: 10.1016/j.jnutbio.2012.02.012
17. Pruijm M, Ponte B, Ackermann D, Vuistiner P, Paccaud F, Guessous I, Ehret G, Eisenberger U, Mohaupt M, Burnier M, Martin PY, Bochud M., Heritability, determinants and reference values of renal length: a family-based population study. Eur Radiol 2013 23 2899 2905. doi: 10.1007/s00330-013-2900-4
18. Pruijm MT, Wuerzner G, Glatz N, Alwan H, Ponte B, Ackermann D, Burnier M, Bochud M., A new technique for simultaneous validation of two manual nonmercury auscultatory sphygmomanometers (A&D UM-101 and Accoson Greenlight 300) based on the International protocol. Blood Press Monit 2010 15 322 325. doi: 10.1097/MBP.0b013e32833f56a8
19. Bland JM, Altman DG., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 307 310
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 150 604 612
21. Liu YP, Richart T, Li Y, Zhan WW, Staessen JA., Is arterial stiffness related to body height? Hypertension 2010 55 e24 e25. doi: 10.1161/HYPERTENSIONAHA.110.152553
22. Albu A, Fodor D, Bondor C, Crəciun AM., Bone metabolism regulators and arterial stiffness in postmenopausal women. Maturitas 2013 76 146 150. doi: 10.1016/j.maturitas.2013.07.001
23. Gungor O, Kircelli F, Carrero JJ, Hur E, Demirci MS, Asci G, Toz H., The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients. Clin Nephrol 2011 75 491 496
24. Hermans MM, Vermeer C, Kooman JP, Brandenburg V, Ketteler M, Gladziwa U, Rensma PL, Leunissen KM, Schurgers LJ., Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index. Blood Purif 2007 25 395 401. doi: 10.1159/000108629
25. Shroff RC, Shah V, Hiorns MP, Schoppet M, Hofbauer LC, Hawa G, Schurgers LJ, Singhal A, Merryweather I, Brogan P, Shanahan C, Deanfield J, Rees L., The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Nephrol Dial Transplant 2008 23 3263 3271. doi: 10.1093/ndt/gfn226
26. Schurgers LJ, Uitto J, Reutelingsperger CP., Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med 2013 19 217 226. doi: 10.1016/j.molmed.2012.12.008
27. Cranenburg EC, Koos R, Schurgers LJ, Magdeleyns EJ, Schoonbrood TH, Landewé RB, Brandenburg VM, Bekers O, Vermeer C., Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species. Thromb Haemost 2010 104 811 822. doi: 10.1160/TH09-11-0786
28. Braam LA, Hoeks AP, Brouns F, Hamulyák K, Gerichhausen MJ, Vermeer C., Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost 2004 91 373 380. doi: 10.1160/TH03-07-0423
29. Knapen MH, Braam LA, Drummen NE, Bekers O, Hoeks AP, Vermeer C., Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: double-blind randomised clinical trial. Thromb Haemost 2015 113. doi: 10.1160/TH14-08-0675
30. Mac-Way F, Poulin A, Utescu MS, De Serres SA, Marquis K, Douville P, Desmeules S, Larivière R, Lebel M, Agharazii M., The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study. Nephrol Dial Transplant 2014 29 2113 2120. doi: 10.1093/ndt/gfu224
31. Liu YP, Gu YM, Thijs L, Inactive matrix Gla protein is causally related to adverse health outcomes: a Mendelian randomization study in a Flemish population. Hypertension 2015 65 463 470. doi: 10.1161/HYPERTENSIONAHA.114.04494
32. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C., Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005 25 1629 1633. doi: 10.1161/01.ATV.0000173313.46222.43
33. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P, Duvivier C, Peslin R, Atkinson J., Calcification of medial elastic fibers and aortic elasticity. Hypertension 1997 29 999 1006
34. Greenwald SE., Ageing of the conduit arteries. J Pathol 2007 211 157 172. doi: 10.1002/path.2101
35. Mackey RH, Venkitachalam L, Sutton-Tyrrell K., Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007 44 234 244. doi: 10.1159/000096744
36. Proudfoot D, Shanahan CM, Weissberg PL., Vascular calcification: new insights into an old problem. J Pathol 1998 185 1 3
37. Murshed M, Schinke T, McKee MD, Karsenty G., Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004 165 625 630. doi: 10.1083/jcb.200402046
38. Malhotra R, Burke MF, Martyn T, Inhibition of bone morphogenetic protein signal transduction prevents the medial vascular calcification associated with matrix Gla protein deficiency. PLoS One 2015 10 e0117098. doi: 10.1371/journal.pone.0117098
39. Gallieni M, Fusaro M., Vitamin K and cardiovascular calcification in CKD: is patient supplementation on the horizon? Kidney Int 2014 86 232 234. doi: 10.1038/ki.2014.24
40. Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GF., Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-Analysis. Ann Intern Med 2012 157 263 275. doi: 10.7326/0003-4819-157-4-201208210-00007
41. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E., Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999 21 142 144. doi: 10.1038/5102
42. Meier M, Weng LP, Alexandrakis E, Rüschoff J, Goeckenjan G., Tracheobronchial stenosis in Keutel syndrome. Eur Respir J 2001 17 566 569
43. Khosroshahi HE, Sahin SC, Akyuz Y, Ede H., Long term follow-up of four patients with Keutel syndrome. Am J Med. Genet A 2014 164A 2849 2856. doi: 10.1002/ajmg.a.36699
44. Cranenburg EC, VAN Spaendonck-Zwarts KY, Bonafe L, Mittaz Crettol L, Rödiger LA, Dikkers FG, VAN Essen AJ, Superti-Furga A, Alexandrakis E, Vermeer C, Schurgers LJ, Laverman GD., Circulating matrix γ-carboxyglutamate protein (MGP) species are refractory to vitamin K treatment in a new case of Keutel syndrome. J Thromb Haemost 2011 9 1225 1235. doi: 10.1111/j.1538-7836.2011.04263.x
45. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R., Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990 15 827 832
46. Davila JA, Johnson CD, Behrenbeck TR, Hoskin TL, Harmsen WS., Assessment of cardiovascular risk status at CT colonography. Radiology 2006 240 110 115. doi: 10.1148/radiol.2401050948
47. Dalmeijer GW, van der Schouw YT, Magdeleyns E, Ahmed N, Vermeer C, Beulens JW., The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein. Atherosclerosis 2012 225 397 402. doi: 10.1016/j.atherosclerosis.2012.09.019.